PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Inhalation of 5% clary oil led to a significant decrease in systolic blood pressure compared to control and lavender oil groups in female patients with urinary incontinence [PMID:23360656]
Clary sage essential oil is used as an aromatherapy agent to relieve anxiety, stress, and depression [PMID:19831048]
In rats, clary sage oil (5%, 10%, or 20%) was effective in treating chronic immobilization stress-induced endothelial dysfunction [PMID:25311097]
Clary sage oil demonstrates antibacterial activity against Staphylococcus aureus, S. epidermidis, S. xylosus, and Pseudomonas aeruginosa [PMID:25821423, PMID:34770858, PMID:7765213]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36263135 (2022) — The bioactivities of sclareol: A mini review. · Frontiers in pharmacology
- 2.PMID: 39545222 (2024) — Safety and efficacy of a feed additive consisting of an essential oil derived from the flowering stems of Salvia sclarea L. (clary sage oil) for use in all animal species (FEFANA asbl). · EFSA journal. European Food Safety Authority
- 3.PMID: 19831048 (2009) — Essential oils and anxiolytic aromatherapy. · Natural product communications
- 4.PMID: 40347925 (2025) — Comprehensive multi-omics and pharmacokinetics reveal sclareol's role in inhibiting ocular neovascularization. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 5.PMID: 39911870 (2025)